(IN BRIEF) According to an independent report, the cost of prescription medicines to the NHS in England reached a record high of £17.2 billion in the financial year 2021-2022. The report reveals that NHS spending on branded medicines has been … Read the full press release
Posted in Education, Government, Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Beth Woods, cancer drugs, cost of prescription medicines, COVID-19 vaccines, Dr Huseyin Naci, Dr James Lomas, e Voluntary Scheme for Branded Medicines Pricing and Access, immunosuppression, London School of Economics and Political Science, London School of Hygiene & Tropical Medicine, LSE, LSHTM, malignant disease, medicines, NHS, REPORT, respiratory system disorders, University of York, VPAS
Not intended for U.S. and UK Media (IN BRIEF) Bayer AG has partnered with Acuitas Therapeutics, Inc. to enhance its gene therapy portfolio. Acuitas’ lipid nanoparticle (LNP) delivery technology will enable targeted and efficient delivery of gene editing RNA components … Read the full press release
Posted in Business, Germany, Healthcare, Pharma & Biotech
Tagged Acuitas Therapeutics, AskBio, Asklepios BioPharmaceutical, Bayer, Clinically validated, components, DNA, Dr. Thomas Madden, Friedemann Janus, gene editing, gene therapy, High potency ionizable lipid technology, Jost Reinhardt, lipid nanoparticle, LNP, LNP carriers, messenger RNA, molecular therapeutics, mRNA, RNA, vivo gene editing
Not intended UK Media (IN BRIEF) Bayer and Cedilla Therapeutics have entered into an exclusive license agreement to develop and commercialize Cedilla’s CyclinE1/CDK2 complex inhibitors for precision oncology. These inhibitors target oncogenic drivers and offer a unique method of action, … Read the full press release
Posted in Business, Germany, Healthcare, Pharma & Biotech
Tagged Bayer, CDK2, CDK2 inhibitors, Cedilla, Cedilla Therapeutics, Cyclin Dependent Kinase 2, cyclin E, CyclinE1, CyclinE1/CDK2 complex inhibitors, Dominik Ruettinger, Exclusive license agreement, M.D., Neil Exter, oncogenic drivers, Ph.D., precision oncology
(IN BRIEF) Loughborough University and the University of Oxford have collaborated on a groundbreaking study that has resulted in the development of a small molecule probe. This probe specifically binds to inositol pyrophosphate (5-PP-InsP5), a crucial cellular messenger involved in … Read the full press release
Posted in Education, Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged 5-PP-InsP5, biological processes, cell growth, cellular messenger, Dr Felix Plasser, Dr Stephen Butler, enzyme regulation, Fathima Jamion, inositol pyrophosphate, Loughborough University, Megan Shipton, Pick of the Week, Professor Barry Potter, programmed cell death, regulator of blood glucose levels, small molecule probe, therapeutic drugs, University of Oxford
(IN BRIEF) The European Bank for Reconstruction and Development (EBRD) has granted a loan of $23 million to Meros Pharm, a leading pharmaceutical distributor in Uzbekistan. The loan will support Meros Pharm’s expansion plans by providing the necessary working capital … Read the full press release
Posted in Banks, Business, Financial, Investment, Pharma & Biotech, United Kingdom
Tagged EBRD, loan, Meros Pharm, pharmaceutical distributors, Uzbekistan
(IN BRIEF) Royal Philips is showcasing its end-to-end cardiology solutions at EuroPCR 2023 to deliver improved heart care with greater efficiency. The company’s comprehensive cardiology portfolio integrates imaging, devices, software, informatics, and services at every stage of the patient journey. … Read the full press release
Posted in France, Healthcare, Netherlands, Pharma & Biotech, Technology
Tagged angio iFR, AngioSculpt Evo, atherectomy solutions, Azurion, cardiology solutions, coronary imaging, coronary laser atherectomy catheter, DCR4Contrast, DEFINE-FLAIR, Dr. Takayuki Warisawa, Dr. Yoshinobu Onuma, Dynamic coronary roadmap, EchoNavigator, ELCA, EuroPCR, European Association of Percutaneous Cardiovascular Interventions, health technology, iFR, IntraSight, intravascular ultrasound, IVUS catheters, OmniWire, PCI patients, percutaneous coronary intervention, Philips Dynamic Coronary Roadmap, Prof. Javier Escaned, Radiographic imaging, ReVEAL iFR, Royal Philips, RX PTCA Scoring Balloon Catheter, SyncVision
HORIZON-RIA PROJECT GRANTED FOR THE EARLY DETECTION OF SEPSIS AT THE POINT-OF-CARE DISRUPTIVE SOLUTION FOR SEPSIS DIAGNOSIS AT THE POINT OF CARE THAT WILL OFFER MULTIPLEXED (WITHIN A SINGLE TEST) (IN BRIEF)The AMBROSIA project has been granted under the call … Read the full press release
Posted in Czech Republic, Education, European Union, France, Greece, Healthcare, Ireland, Netherlands, News, Pharma & Biotech, Science, Spain, Switzerland, Technology, United Kingdom
Tagged AMBROSIA, Argotech, Aristotle University of Thessaloniki, Biopix DNA Technology P.C., Catalan Institute of Nanoscience and Nanotechnology, diagnostics, Dr. Alexandros Pantazis, HORIZON-RIA, intelligent sepsis diagnosis, Ligentec, Microfluidics, microLIQUID, nucleic acids, Optical Sensor, PoC, PoC sepsis diagnostic unit, Point of Care, Prof. Nikos Pleros, SEPSIS, SMART PHOTONICS BV, University of Bourgogne, University of Ioannina, University of Southampton, Vall d'Hebron Research Institute, X-Celeprint
(IN BRIEF) Sandoz to commercialize six products exclusively in the US following distribution and collaboration agreement with Adalvo. The products are aimed at treating disorders that affect millions of people in the US each year, including antifungal/antibiotic, oncology, and pulmonary. … Read the full press release
Posted in Business, Healthcare, Management, News, Pharma & Biotech, Switzerland
Tagged Adalvo, Richard Saynor, Sandoz, treatments, US
(IN BRIEF) Boehringer Ingelheim has begun construction on a new Chemical Innovation Plant at its headquarters in Ingelheim, Germany. The €285 million investment will develop manufacturing processes for active pharmaceutical ingredients and produce drugs for clinical trial phases, enabling Boehringer … Read the full press release
(IN BRIEF) Krka, a Slovenian pharmaceutical company, has been awarded the title of the most energy-efficient company at the 25th conference of energy experts in Slovenia. The awards were given to Krka for its integrated, efficient, and sustainable management of … Read the full press release
Posted in Awards, Energy, Gas & Oil, Environment, Industrial, Management, News, Pharma & Biotech, Slovenia
Tagged Award, Dnevi energetikov conference, Krka, sustainable energy management
(NOTIZIA IN BREVE) Antibiotice SA, uno dei principali produttori rumeni di farmaci generici, ha firmato un nuovo accordo di consulenza con la Banca europea per gli investimenti (BEI) per contribuire a sviluppare la sua capacità di sviluppare nuovi farmaci generici, … Read the full press release
Posted in Banks, Business, European Union, Financial, Investment, Pharma & Biotech, Romania
Tagged Antibiotice SA, azienda rumena, EIB, farmaci generici, Hristo Stoykov, Ioan Nani
(IN BRIEF) Antibiotice SA, a leading Romanian manufacturer of generic drugs, has signed a new advisory agreement with the European Investment Bank (EIB) to help build its capacity to develop new generic drugs, improve production processes, and strengthen its local … Read the full press release
Posted in Banks, Business, European Union, Financial, Investment, Pharma & Biotech, Romania
Tagged Antibiotice SA, EIB, generic drugs, Hristo Stoykov, Ioan Nani, Romanian company
(IN KÜRZE) Die LEGO Group und Novo Nordisk haben sich mit European Energy zusammengetan, um E-Methanol, eine kohlenstoffärmere Alternative zu herkömmlichem Kunststoff, für einen Teil ihrer Materialproduktion zu verwenden. European Energy wird E-Methanol aus erneuerbarer Energie und biogenem CO2 produzieren, … Read the full press release
(IN BRIEF) The LEGO Group and Novo Nordisk have partnered with European Energy to use e-methanol, a lower-carbon alternative to conventional plastic, for some of their material production. European Energy will produce e-methanol from renewable energy and biogenic CO2, and … Read the full press release
(IN KÜRZE) Das BioSense Institute in Novi Sad hat ein neues Gebäude eröffnet, das moderne Einrichtungen für wissenschaftliche Forschung und Geschäftsvorhaben in den Bereichen Landwirtschaft und Biotechnologie bietet. Das 34-Millionen-Euro-Projekt wurde mit 14 Millionen Euro an EU-Zuschüssen, 20 Millionen Euro … Read the full press release
Posted in Agriculture, Banks, Education, European Union, Financial, Investment, Pharma & Biotech, Science, Serbia, Small Business, Technology
Tagged Ana Brnabić, ANTARES-Projekt, BioSense Institute, biotechnologie, Biowissenschaften, Branko Ružić, EIB, Europäische Investitionsbank, Felicitas Riedl, Igor Mirović, Jelena Begović, Jelena Tanasković, Jugend Mariya Gabriel, Landwirtschaft, Mariya Gabriel, Marko Blagojević, Mihailo Jovanović, Novi Sad, Serbien, start-ups, Tanja Miščević, Universität Novi Sad, Vladimir Crnojević, wissenschaftliche Forschung
(IN BRIEF) The BioSense Institute in Novi Sad has opened a new building offering modern facilities for scientific research and business ventures in the fields of agriculture and biotechnology. The €34 million project was financed by €14 million in EU … Read the full press release
Posted in Agriculture, Banks, Education, European Union, Financial, Investment, Pharma & Biotech, Science, Serbia, Small Business, Technology
Tagged agriculture, Ana Brnabić, ANTARES project, BioSense Institute, biotechnology, Branko Ružić, EIB, European Investment Bank, Felicitas Riedl, Igor Mirović, Jelena Begović, Jelena Tanasković, life sciences, Mariya Gabriel, Marko Blagojević, Mihailo Jovanović, Novi Sad, scientific research, SERBIA, Startups, Tanja Miščević, University of Novi Sad, Vladimir Crnojević, Youth Mariya Gabriel
(NOTICIA EN BREVE) Sanofi ha nombrado a Elisabeth Moreno, exministra francesa de Igualdad de Género, Diversidad e Igualdad de Oportunidades, para su Junta de Diversidad, Equidad e Inclusión (DE&I) para los próximos tres años. El consejo asesor se creó en … Read the full press release
Posted in Business, France, Management, Pharma & Biotech
Tagged Caroline Casey, Dell, derechos humanos, diversidad, Dr. Rohini Anand, Elisabeth Moreno, Emmanuel Macron, France Télécom, Hewlett Packard, igualdad de género, Igualdad de oportunidades, Junta DE&I, Lenovo, lucha contra la discriminación, nombramiento, Paul Hudson, Sanofi
(IN BRIEF) Sanofi has appointed Elisabeth Moreno, former French Minister for Gender Equality, Diversity and Equal Opportunities, to its Diversity, Equity and Inclusion (DE&I) Board for the next three years. The advisory council was created in 2022 to support Sanofi’s … Read the full press release
Posted in Business, France, Management, Pharma & Biotech
Tagged appointment, Caroline Casey, DE&I Board, Dell, diversity, Dr. Rohini Anand, Elisabeth Moreno, Emmanuel Macron, Equal opportunities, fight discrimination, France Télécom, gender equality, Hewlett Packard, human rights, Lenovo, Paul Hudson, Sanofi
(IN BRIEF) AstraZeneca is set to present data on its Vaccines and Immune Therapies portfolio at the European Congress of Clinical Microbiology & Infectious Diseases. Among the data to be presented will be details on the progress of AstraZeneca’s Vaccines … Read the full press release
Posted in Business, Healthcare, Industrial, Management, Media, News, Pharma & Biotech, Science, United Kingdom
Tagged AstraZeneca, AZD3152, Beyfortus, ECCMID 2023, Evusheld, Immune Therapies, Iskra Reic, vaccines, Vaxzevria
(IN BRIEF) AstraZeneca will showcase new data from its industry-leading Oncology pipeline and portfolio at the American Association for Cancer Research Annual Meeting. A total of 70 presentations will be given, including a plenary presentation on the AEGEAN Phase III … Read the full press release
Posted in Business, Healthcare, Industrial, Management, News, Pharma & Biotech, Science, United Kingdom
Tagged AstraZeneca, AZD5335, AZD9592, early-stage, Imfinzi, lung cancer, oncology, Susan Galbraith, treatment
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?